0001021432-17-000403.txt : 20171213
0001021432-17-000403.hdr.sgml : 20171213
20171213150003
ACCESSION NUMBER: 0001021432-17-000403
CONFORMED SUBMISSION TYPE: 15-12G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20171213
DATE AS OF CHANGE: 20171213
EFFECTIVENESS DATE: 20171213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Regenerative Technologies & therapies Inc.
CENTRAL INDEX KEY: 0001644828
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 474460112
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 15-12G
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55480
FILM NUMBER: 171253664
BUSINESS ADDRESS:
STREET 1: 888 PROSPECT STREET
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 888-263-2955
MAIL ADDRESS:
STREET 1: 888 PROSPECT STREET
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: A2M Regenerative Technologies, Inc.
DATE OF NAME CHANGE: 20151120
FORMER COMPANY:
FORMER CONFORMED NAME: Southern Ridge Acquisition Corp
DATE OF NAME CHANGE: 20150611
15-12G
1
form15formglobal.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-55480
GLOBAL REGENERATIVE TECHNOLOGIES & THERAPIES INC.
(Exact name of registrant as specified in its charter)
888 Prospect Street, Suite 200
La Jolla, California 92037
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
Common Stock
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to
file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to
file reports:
Rule 12g-4(a)(1) / X /
Rule 12g-4(a)(2) /__/
Rule 12h-3(b)(1)(i) / X /
Rule 12h-3(b)(1)(ii) /__/
Rule 15d-6 /__/
Approximate number of holders of record as of the certification or
notice date: 4 (number of shareholders)
Pursuant to the requirements of the Securities Exchange Act of
1934, GLOBAL REGENERATIVE TECHNOLOGIES & THERAPIES INC. has caused
this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
Date: December 13, 2017 By: Stefan Kasian
Chief Executive Officer